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Abstract 
Objective: Core stabilization exercise (CSE) is widely prescribed to treat chronic non-specific 
low back pain (CLBP).  However, the neuro-endogenous mechanism behind the pain relieving 
effect by CSE is still unknown.  The main objective of the study was to measure the levels of 
plasma beta-endorphin (PB) and plasma cortisol (PC) under CSE, placebo and control conditions 
in CLBP patients. 
Methods:  Twenty-four subjects with CLBP participated in a randomized, placebo-controlled, 
cross-over design study.  There were 3 experimental exercise conditions; control condition 
(positioning in crook lying and rest), placebo condition (passive cycling in crook lying using 
automatic cycler), and CSE on a Pilates device tested with 48 hours interval between sessions by 
concealed randomization. Blood sample was collected before and after the exercise conditions.    
PB and PC were measured through enzyme-linked immunosorbent assay and 
electrochemiluminescence in Cobas E411 auto analyzer.  
Result:  PB level showed a significant difference before and after the CSE condition (P<0.05), 
while no significant differences were noticed in control and placebo exercise conditions.  Also, 
the trend of elevation of PB under the CSE was significantly different when compared to the 
placebo and control conditions (P<0.01).  In contrast, the PC level remains unchanged in all the 
three conditions.  
Conclusion:  CSE potentially influences PB level but not PC level among CLBP patients.  The 
mechanism of action for pain relieving effect by CSE  might be possibly related to an 
endogenous opioid mechanism as part of its effects, and might not be involved with ‘stress 
induced analgesia mechanism.   
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Introduction 
Lumbopelvic core stability exercise training (LPST) is a common therapeutic 
management in day to day practice for the low back pain patients.  The LPST exercises recruit 
and train certain specific muscles such as transverses abdominis and multifidus in order to 
provide spinal stabilization.
1
  Evidence from the systematic reviews suggests that the LPST is an 
effective treatment for low back pain patients as it reduces pain and improves function.
2
   The 
mechanical and neuro-physiological effects of the LPST such as improved contractility of core 
muscle, enhanced feed forward mechanism and  improved lumbopelvic stability are accounted as 
established effects for pain reduction among patients with CLBP.
3-6
  While the mechanical 
effects of LPST are well documented, the biochemical effects of the LPST behind pain relief are 
yet to be fully understood. Exercise can cause endogenous induced analgesia through release of 
endogenous opioids.
7 
However, it is not clear whether the LPST can release the endogenous 
opioids that may be behind the mechanism of pain relief among CLBP patients.     
 
Endogenous opioids have been found to have analgesic effect in a variety of chronic pain 
syndromes including CLBP.
8  
Beta-endorphin (BE) is one such peptide released with 
adrenocorticotrophic hormone from the anterior pituitary gland as a result of exercise stress.
9
 The 
release of BE works on the endogenous opioid receptors and acts on the descending inhibitory 
system that modulates pain at the spinal cord level.
10
 An appropriate metabolic and thermal 
stress is required in any exercise for the release of BE.
11
  Moreover, it is suggested that exercise 
intensity and BE release are correlated in producing the opioid induced analgesic effect in human 
beings after exercises.
12
  However, it is not sure whether the LPST has enough physical stress to 
induce BE release and to increase PB  in CLBP. 
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Evidence suggests that functional somatic symptoms like CLBP are often associated with 
physical and mental stress.
13,14
  Cortisol is a primary peripheral hormone from hypothalamic-
pituitary adrenocortical activity that reflects the coping mechanism of body for stress response 
and pain adaptation.
13,14
   The cortisol is released by the adrenal cortex by stimulation of 
adrenocorticotrophic hormone at the anterior pituitary and corticotrophin releasing factor from 
the paraventricular nucleus of the hypothalamus.
15  
The mental and physical stress associated 
with an acute pain and anxiety causes an increased hypothalamus-pituitary-adrenal axis 
activation (HPA).
13
 Furthermore, the altered activity of HPA axis contributes to evolution of 
stressful characteristics of a clinical problem into chronic pain disorder.
13
  An increased 
concentration of the PC has been postulated to cause attenuation of pain perception in acute 
stress conditions.
16
 Also, the cortisol regulates sympathetic and opioid mechanisms related with 
central pain processing.
15
  While altered level of the stress hormone cortisol influences stress-
somatic complaints in functional somatic syndromes, such theory may exists in conditions like 
CLBP.
17
  Therefore, in a common stressful condition like back pain or a physical stressor like 
exercise, it may be possible that both the BE and cortisol are released as response from body 
mechanism to exhibit endogenous opioid induced analgesia and stress induced analgesia 
respectively.  
 
While clinical studies have focused on roles of the BE and cortisol on health, the 
biochemical changes on the PB and PC levels after the LPST have not been studied previously.  
Moreover, a recent systematic review has a conclusion that there were limited evidence to 
conclude whether or not the exercise therapy induces pain modulating substances, and therefore 
warrants for an investigation to explore the effects of the LPST on the PB and PC.
18
  In addition, 
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stress induced analgesia and placebo induced analgesia are two of several other clinical 
reasoning mechanisms proposed to effect low back pain patients.
19,20
  Thus, it is appropriate to 
do a deductive reasoning to differentiate and investigate the real effects of the LPST on the PB  
and PC in comparison to the placebo  and controlled intervention. Therefore, the main aim of the 
current study was to investigate the effects of three groups of exercise interventions; the lumbo-
pelvic core stability training (LPST), the placebo (automated passive cycling training), and the 
control (rest) interventions on the levels of PB and PC on CLBP patients.  The current study 
hypothesized that the LPST might increases the PB and reduces the plasma cortisol when 
compared to the placebo and control interventions among the patients with CLBP.  The 
information from the study may help clinicians to understand the potential biochemical effects of 
the LPST against the other exercise regimes.  Such knowledge may assist the clinicians to design 
appropriate exercise prescription in low back pain rehabilitation.   
 
Methods 
Subjects 
A total of 24 participants (7 males, 17 females; age 33.76 ± 14.51 years) with CLBP 
residing in a community and university area participated in the study.  An advertisement about 
the research study was placed around the community and university locations and the 
participants were recruited through pre-defined inclusion and exclusion criteria.  The participants 
aged 20-35 years with mild to moderate back pain, with a visual analog scale pain score between 
2-7 cm and presence of pain for more than 3 months with location of pain in the area between the 
lowest rib 12
th
 to gluteal folds participated in the study.  Any participants with referred pain or 
neurological involvement in lower limbs, with history of past surgery, with history of smoking, 
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who had history of injury in the last 3 months, were not recruited for the study. In addition, 
pregnant women and women who reported menstruation three days before or three days after the 
study period were not included.  Also, any participants who performed any forms of physical 
exercises regularly were not considered for the study as routine exercises may potentially 
influence the physiological levels of beta endorphins.  None of the participants took stimulants, 
medications, alcohol and involved in heavy physical activities at least 12 hours prior to the test.  
All the participants gave written informed consent to join the study and the whole research 
project was conducted in an outpatient physiotherapy department of a university teaching 
hospital.  A university ethical committee approved the human ethics for the study as per the 
standards of Declaration of Helsinki, Finland.  
 
Study Design 
The effects of the three different groups of intervention; the LPST training, the placebo 
(automated passive cycling training), and the control (rest) group on the levels of plasma BE and 
PC were investigated through a randomized, placebo-controlled, cross over trial.  An envelope 
based concealed randomization and allocation of the participants was used in the study.  Two 
independent physiotherapists who were not the part of the study assisted the process of 
randomization and allocation.  All of the three interventions were numerically coded in an 
opaque sealed envelope and placed in a closed box by one of the independent physiotherapy staff 
prior to the screening of the participants.  The second staff who was not aware of the coded 
allocation sequence for intervention assisted with the screening of the participants for the study 
and collected the written consent.  Then, each of the participants were asked by the other staff to 
choose any one envelope during the first visit and allocated to the corresponding intervention 
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group accordingly.  During the second visit, the same procedure was repeated and the second 
allocation was carried out for the second intervention. The participants went allocated to the third 
intervention based on the last envelope left inside the box.  Thus, the participants crossed over 
from one intervention to the other intervention during the course of the trial.  The cross-over 
design was employed in this study to avoid variations in the physical, physiological and 
psychosocial characteristics among the study participants. 
 
Experimental Exercise Training Conditions 
The three types of exercise interventions; the LPST, the placebo (automated passive 
cycling training), and the control (rest) intervention for this study was implemented as per the 
previously established protocols.
3,4,6
  All the participants performed each type of exercises in a 
controlled environmental room with temperature of 24.5 + 0.5
o
C, relative humidity of 60 + 5%, 
for approximately 15 minutes randomly with 48 hours between sessions to minimize any 
possible carry over effect.  The participants performed all the exercises under the supervision of 
a qualified physiotherapist who had a post graduate clinical training in musculoskeletal 
physiotherapy.  The position of the participants for all types of exercise interventions was supine 
crook lying.  All of the participants received one familiarization trial for each exercise on the day 
of the corresponding exercise intervention. The familiarization trial was strictly maintained to a 
single attempt in order to prevent any learning effects.  The therapist instructed all the 
participants to report any incidence of increased intensity of pain during the course of the 
interventions.  Any participant who reported increased intensity of pain during the intervention 
was stopped from further participation in the trial due to safety and ethical reasons as per the 
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study protocol.  The exercises were monitored and corrected by the therapist if necessary in order 
to adhere to the exercise protocols.   
A Pilates power gym transformer device (Thane Fitness, UK) and air pressure 
biofeedback unit were used to perform the LPST.  For the LPST intervention, the participants lay 
down on the pilates exercise training device with hip and knee flexed to 70
o
 and 90
o
, 
respectively. The core muscle activation was facilitated by encouraging abdominal hollowing 
and co-contraction of trunk muscles. The core muscle contractility and the progression of the 
exercises were monitored by an air pressure biofeedback unit that was also placed beneath the 
lumbar spine from L2 to S1 and inflated to 40 mmHg.  All the participants performed core 
muscle exercise with a resistance of approximately 10% of the body weight using weight pulley 
system on the device incorporating the limb movements in the following progressive order; core 
with alternate hip abduction, core with alternate leg raise, core with both arms adduction, core 
with both arms extension, core with alternate arm lift, core with alternate leg lift, core with 
alternate leg and arm.
3  
Figure 1 shows one of the exercise description of the core stability 
training.
  
The progression of the exercises was stopped when the subject could not maintain the 
registered air pressure at 40 + 10 mmHg.  Every stages of exercise were repeated for 10 times.  
The Placebo (automated passive cycling) intervention was administered by using an automatic 
bicycle (ReckMotomed Viva, RECK Technik, Germany).  In supine crook lying position, the 
participants performed alternate leg movements passively at the speed of 30 revolutions per 
minute (rpm) with their feet attached to the pedals of the automatic bicycle.  For the control (rest) 
intervention, the participants were made to relax completely on the Pilates power gym in the 
similar supine crook lying position.  In addition, both knees were supported by pillows with hip 
flexion of 70
o
 and knee flexion of 90
o 
in order to ensure complete rest and relaxation. 
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Measurements 
Procedures 
A qualified biomedical person who was independent to the study protocol was employed to 
collect the blood samples from the participants.  A 10 ml of blood was drawn from each 
participant through a venipuncture at the cubital vein.  The blood samples from the participants 
were collected at two points such as one minute prior to the exercise intervention and one minute 
after the exercise intervention.  All of the blood samples were collected during the late morning 
period between the time frame of 09:00 hours and 11:00 hours respectively in order to 
standardize the circadian rhythm effects on the blood markers.  The samples of blood were 
collected in vacutainer plastic tubes and stored on an iced container and moved for the 
centrifugation process at the university hospital. 
Plasma β-endorphin 
The PB was collected as per an established protocol.
21
 A 500 μl of plasma was acidified 
with 500 μl of 1% trifluoroacetic acid (TFA) and mixed, then centrifuged at 17,000 × g for 20 
min at 4 degrees Celsius.  A SEP-Column containing 200 mg of C18 was equilibrated by 
washing with 60% acetonitrile in 1% TFA (1 ml, once) followed by 1% TFA (3 ml, 3 times).  
Acidified plasma solution was loaded onto the pre-treated C-18 SEP-COLUMN. The column 
was slowly washed with 1% TFA (3 ml, twice).  The peptide was eluted slowly with 60% 
acetonitrile (3 ml, once). The eluant was collected in a polypropylene tube and evaporated to dry 
in a centrifugal concentrator.  The dried sample was kept at -20
oC.  A 50 μl of sample or 
standard, 25 μl of primary anti-serum, and 25 μl of biotinlyated β-endorphin were added into 
ELISA well plate and incubated for 2 hours at room temperature. The plate was washed 6 times 
with assay buffer and dried by inverting the plate on an absorbent material. A 100 μl of diluted 
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SA-HRP solution was added into each well, except for the blank, and incubated for 1 hour at 
room temperature. The plate was washed again three times and dried. Finally, a 100 μl of TMB 
solution was added to each well, and incubated for 1 hour at room temperature. The reaction was 
stopped with 2N HCl and absorbance was read at 450 nm. The concentration of β-endorphin was 
calculated with the standard curve of standard β-endorphin (0.01-1,000 ng/mL). 
Plasma Cortisol 
The PC levels were detected using Elecsys® Cortisol (Roche) in Cobas E411 auto analyzer. The 
principle of the test was electrochemiluminesence immune assay method. The sample was 
incubated with a cortisol specific biotinylated antibody, a ruthenylated cortisol derivative and 
releasing agent. The antibody binding sites were occupied either by cortisol or the ruthenylated 
derivative, with the proportion of each depending on the concentration of cortisol in the sample. 
Streptavidin-coated micro particles were added to the reaction mixture and the immune 
complexes bind to the solid phase via biotin streptavidin interactions. The reaction mixture was 
transferred to a measuring cell and the micro particles were magnetically captured onto the 
surface of an electrode; unbound sample was washed away before a chemiluminescent reaction 
was induced by applying a voltage to the electrode. The detection limit was 0.5 nmol/L and 
measuring range was 0.5-1,750 nmol/L. 
Data Analysis 
The sample size for the current study was established in previous studies using G*power 
statistical program.
3,6
  A significant alpha level of 0.05 and power analysis of 0.80 with an 
estimated moderate effect size of 0.54 resulted in a sample size of approximately 24 participants 
for this study.  The Shapiro-Wilk test was used for examination of the data normality.  The 
percentage change (%change) of the PB and PC levels were also estimated by the difference 
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between pre- and post-changes divided by hundred. Since the data were not normally distributed, 
the non-parametric statistics, Friedman’s Rank Test and post-hoc analysis by Wilcoxon Signed-
Rank Test were used to analyze the changes of the PB and PC levels after three types of exercise 
interventions. The statistical software package (SPSS) for windows version 20.0 was used to 
analyze the data. 
 
Results 
All of the participants had low back pain with reported pain intensity of 4.28±1.82 cm in 
the pain visual analog scale and the mean duration of the low back pain was 41.54±35.81 
months.  The mean weight and height of the participants were 59.02±9.38 kilograms and 
162.42±10.89 centimeters, respectively.  None of the participants reported any increase in the 
pain intensity during the course of the interventions.   
Table I shows the PB and PC levels in all the three exercise interventions.  The PB and 
PC levels between the three groups of exercise interventions showed no significant difference 
(P>0.05) at baseline measurements.  The percentage change in the level of PB was 
approximately 142.30% which suggested a trend of elevation in the release of PB before and 
after the LPST intervention (P<0.05).  On the other hand, the level of PB dropped with total 
percentage change of -40.59% and -44.18% after the placebo intervention (P<0.001) and control 
(rest) interventions (P<0.001), respectively. The results showed that there was a significant 
difference between the three groups on the total percentage change of the PB after the exercise 
interventions (P<0.01). The results from the levels of PC analysis showed that there was no 
significant difference in the percentage change of PC when compared between the three groups 
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of exercise interventions (P>0.05); the LPST intervention (-15.83%), the placebo (automated 
passive cycling training)          (-33.70%), and the control (rest) intervention (-29.19%). 
 
 
Discussion 
The current study investigated the effects of LPST on the levels of PB and PC in 
comparison to placebo (automated passive cycling) and control (rest) interventions. The PB and 
PC are related substances as both of these substances are generated by hypothalamus-pituitary-
adrenal axis activation in chronic painful conditions such as CLBP or due to the presence of any 
stressors such as physical exercise.  Also, both these substances are reported to modulate pain 
through descending inhibitory system in chronic pain conditions.  Therefore, it is important for 
clinicians to understand the regulating mechanism of these substances after LPST among low 
back pain patients.  The effects of general exercises on the endogenous opioids are well 
established in literature
9
.  However, very limited understanding exists on the effects of the LPST 
on the biochemical substances.
18 In
 our opinion, the current study might be the first study to 
investigate the changes in the PB in combination with PC after administration of the LPST 
intervention. The knowledge on the biochemical changes in PB and PC after LPST may help 
clinicians to understand the mechanism behind the analgesic effect of LPST among low back 
pain patients.  Thus, the current study findings are important to understand the changes in the 
levels of PB and PC after LPST prescription among CLBP.  However, the current study did not 
focused on the correlation between the observed changes in the levels of PB and the pain 
intensity reported among the patients.  Therefore, further studies are warranted in this field 
particularly to report on the levels of PB and PC with regard to changes in the pain intensity 
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among CLBP patients in LPST training as such knowledge may further strengthen the evidence 
for the use of LPST in clinical practice.     
 
The result showed that a trend of increase in the average PB level from 6ng/ml at the 
baseline to 15ng/ml immediately after the LPST intervention.  The result suggested that the 
LPST exercise could influence circulating PB levels in blood stream which might explain as one 
of the possible facets for pain suppression mechanisms based on the endogenous pain-relieving 
peptides in CLBP.   Past evidences that supports an increase in the plasma concentration of 
serotonin after application of lumbar stabilization exercises among low back pain patients may 
convince to accept the rationale that the LPST increased the levels of PB among the participants 
in the current study.
22,23  
Exercise intensity in relation to the release of PB has been discussed in 
literatures.
24,25,26
  A critical intensity of exercise is pre requisite for elevation of PB  levels in 
blood stream.  An exercise intensity exceeding 60%-80% VO2 max was reported to increase the 
blood BE levels in most individuals.
25  
It was possible that the LPST  may provide an adequate 
stimulus to trigger the release of pain relieving peptides.  As none of the participants reported 
any increase in the pain intensity during the course of interventions, perhaps it could be 
suggested that the observed elevation in the levels of PB might be directly related to the LPST 
and not as a result of increased pain while performing the intervention.  On the other hand, no 
elevated levels of PB was observed in the placebo (passive automated cycle) and control (rest) 
interventions.  It could be explained that these two forms of interventions did not have adequate 
physical stimulants to release PB in comparison to LPST among CLBP.  
The result showed that there was no significant change in the levels of PC between the 
three types of exercise intervention groups.  Cortisol is released by adrenal cortex following 
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physiological and psychological stress.
11  
The range of PC level in this current study was found 
to be within the normal range.
27  
Excessive release of cortisol has negative effect on muscle, 
immune cell function and metabolism.
28
  Also, when cortisol is released higher than the normal 
range, it is counterproductive to optimal tissue repair and remodeling.
28  
Exercise is a primary 
stimulant for the release of PC which depends on exercise protocols, where intensive anaerobic 
demands increases PC while moderate aerobic exercise are reported not to elicit any responses.
29
 
The result of the current study might explain that LPST intervention possibly belong to moderate 
intensity which was evidenced by the fact that the percentage change of PC levels were not 
elevated.  In our opinion, the relationship between the level of PC and PB with the intensity of 
LPST using tools such as perceived exertion scale needs to be ascertained in future trials as it 
may help clinicians to understand the dosage and intensity behind LPST for the desired 
therapeutic effects from endogenous opioids.  It could be suggested that although the LPST 
might contribute to endogenous induced analgesic response as supported by elevated PB levels, 
the participants were not stressed due to LPST or laboratory environment during the study. 
Absence of a significant difference in the percentage change of PC levels between the three 
exercise intervention groups hinted that the LPST could be considered as a safe therapeutic 
exercise with possibly endogenous opioid induced analgesic effects as part of its actions.  
 There is a huge paucity of knowledge in evidence based practice towards the effects of 
LPST on the PB and PC in CLBP.  Therefore, further research is recommended on this field on 
topics such as establishing a dosage and response between LPST, PB and PC, understanding the 
pain modulating effects by PB and PC following LPST and alterations in the autonomic nervous 
system.   Any spinal therapies such as spinal mobilization and spinal manipulation were reported 
to have an effect on the autonomic nervous system and cardio vascular system.
30,31,32
  It is 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
15 
 
suggested that stimulation of spinal joints through manipulative therapy decreases heart rate and 
blood pressure through the autonomic system activity.
33
 Furthermore, aberrant stimulation of the 
spinal or paraspinal structures were reported to cause segmentally organized reflex responses of 
the autonomic system and visceral function.
32
  Also, the endogenous opioid system is activated 
by various stimuli such as hypoglycaemia, severe hypotension, acute myocardial ischemia and 
congestive cardia failure.
34
  As LPST is believed to act on the segmental stability of the lumbar 
spine, it may be relevant to investigate the effects of LPST on PB and PC in the context of 
autonomic nervous system activity, visceral function and cardiovascular system.  Therefore, 
future studies may investigate the mechanism of interaction between PB, PC, autonomic, visceral 
and cardiovascular during LPST among CLBP.  The current study contributes to some important 
clinical implications for clinicians towards rehabilitation of CLBP.  Neuroendocrine and 
neuroimmune effects are two important output mechanisms hypothesized in clinical reasoning of 
CLBP.  The current study might facilitate an understanding of the levels of PB and PC among 
patients with low back pain as indicators of neuroendocrine and neuroimmune mechanisms.  
Such knowledge may help clinician to strengthen the hypothesis on the pain and tissue healing 
mechanisms in management of CLBP. Also, the study might provide an explanation over the 
analgesic mechanism reported in LPST by documenting the biochemical changes in levels of 
plasma BE.  Additionally, the current study might help clinicians to differentiate endogenous 
opioid versus stress related analgesia in low back pain conditions.    
The study acknowledges few limitations.  The study did not directly investigate the 
changes in the pain intensity in relationship to the changes with the levels of PB and PC during 
LPST.  Therefore, it was not possible to comment on the direct pain inhibition effects by the 
levels of PB and PC observed during the study after the LPST.  The smaller sample size could be 
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considered as another limitation.  Nevertheless, the current study was the first study to report on 
the effects of LPST on PB and PC, thereby it might be useful for other researchers to calculate an 
adequate sample size in further studies on this topic.  Various sub stages (acute versus sub-acute) 
and sub populations of low back pain were not taken into account while sample recruitment.  
Therefore, the study findings may differ in different sub populations of low back pain and hence, 
it requires further investigations in future studies.  The outcome of the study did not consider 
long term follow up of the PB and PC levels.  However, the current study design was not 
appropriate to evaluate long term follow up, as several confounding factors such as neuroticism, 
positive and negative emotions, sleep deprivation, socio-economical and psychosocial variables 
might influence the PB  and PC levels in a longitudinal design. Therefore, the clinicians may 
consider all of the above limitations before translating the study findings to the wider clinical 
practice.    
 
Conclusion 
The LPST intervention potentially increased the PB levels when compared to placebo and 
control interventions in CLBP.  In addition, the percentage change of plasma cortisol levels 
remains unchanged after LPST intervention. Further studies are advocated to confirm and 
translate the study findings to a wider clinical practice.  
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Table I. Data of beta-endorphin and cortisol levels, which are showed as mean + standard deviation (SD) and 
overall percentage change (%Ch) values across all three experimental conditions (i.e., core exercise, placebo, 
control). 
 Conditions 
 
Outcomes Core Exercise Placebo Control 
 
 Pre- Post- %Ch Pre- Post- %Ch Pre- Post- %Ch 
 
Beta-
endorphin 
6.24 
(17.10) 
15.11
*
 
(32.95) 
142.30%
a,b
 
 
6.02 
(11.30) 
3.58 
(9.57) 
-40.59%
**
 
 
10.75 
(19.20) 
6.00 
(16.06) 
-44.18%
***
 
 
 
Plasma 
cortisol 
8.91 
(4.61) 
7.50 
(4.95) 
-15.83%  
 
10.48 
(6.97) 
6.95 
(3.79) 
-33.70% 
 
8.81 
(4.76) 
6.24 
(4.31) 
-29.19% 
 
 
Unit: plasma beta-endorphin (ng/ml), Plasma cortisol (ng/ml) 
Note: No significant differences of the baseline data among three conditions (P>0.05) 
*
Significant differences between pre-post under core stability exercise group (P<0.01) 
**
Significant differences between pre-post under placebo exercise group (P<0.001) 
***
Significant differences between pre-post under control group (P<0.001) 
a
 Significant differences between placebo (P<0.01) 
b
 Significant differences between control (P<0.01) 
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Legends: 
Table Caption: 
Table I. Data of beta-endorphin and cortisol levels, which are showed as mean + standard deviation (SD) and 
overall percentage change (%Ch) values across all three experimental conditions (i.e., core exercise, placebo, and 
control). 
Figure Caption: 
Figure 1: A description of one of the core stabilization exercise with alternate leg lifting on the Pilates power gym 
device 
Figure 1
Click here to download high resolution image
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